MCK (McKesson) Total Liabilities : $73,785 Mil (As of Dec. 2024)

View and export this data going back to 1987. Start your Free Trial

What is McKesson Total Liabilities?

McKesson's Total Liabilities for the quarter that ended in Dec. 2024 was $73,785 Mil.

McKesson's quarterly Total Liabilities increased from Jun. 2024 ($73,051.00 Mil) to Sep. 2024 ($75,071.00 Mil) but then declined from Sep. 2024 ($75,071.00 Mil) to Dec. 2024 ($73,785.00 Mil).

McKesson's annual Total Liabilities declined from Mar. 2022 ($65,090.00 Mil) to Mar. 2023 ($63,810.00 Mil) but then increased from Mar. 2023 ($63,810.00 Mil) to Mar. 2024 ($69,042.00 Mil).

McKesson Total Liabilities Historical Data

The historical data trend for McKesson's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Total Liabilities Chart

McKesson Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

54,536.00

63,569.00

65,090.00

63,810.00

69,042.00

McKesson Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															68,194.00	69,042.00	73,051.00	75,071.00	73,785.00

McKesson Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

McKesson's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	52357	+	(7045	+	8723
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	917	+	0	+	0)
	=	69,042

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	67443	-	-1599
	=	69,042

McKesson's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	58562	+	(5911	+	8220
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1092	+	0	+	0)
	=	73,785

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	71081	-	-2704
	=	73,785

McKesson Total Liabilities Related Terms

Thank you for viewing the detailed overview of McKesson's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Corp (NYSE:MCK) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

0JZU:UK MCK:Germany MCK:Germany M1CK34:Brazil

Address

6555 State Highway 161, Irving, TX, USA, 75039

Website

https://www.mckesson.com

McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Executives

Brian S. Tyler	officer: Chief Executive Officer	MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Leann B Smith	officer: EVP & Chief HR Officer	6555 NORTH STATE HWY 161, IRVING TX 75039
Maria Martinez	director	THE LANDMARK @ 1 MARKET STREET, SUITE 300, SAN FRANCISCO CA 94105
Thomas L Rodgers	officer: EVP, Chief Strategy & BDO	6555 NORTH STATE HWY 161, IRVING TX 75039
Britt J. Vitalone	officer: EVP & CFO	MCKESSON CORPORATION, 6555 STATE HWY 161, IRVING TX 75039
Susan Nowakowski	director	14778 EL RODEO CT., RANCHO SANTA FE CA 92067
Rutledge Napoleon B Jr	officer: SVP, Controller & CAO	2999 WILDWOOD PARKWAY, ATLANTA GA 30339
Lori A. Schechter	officer: EVP, Chief Legal Officer & GC	MCKESSON CORPORATION, 6555 NORTH STATE HWY 161, IRVING TX 75039
Nancy Flores	officer: EVP, CIO & CTO	6555 NORTH STATE HWY 161, IRVING TX 75039
Tracy Faber	officer: EVP & Chief HR Officer	6555 NORTH STATE HWY 161, IRVING TX 75039
Donald R Knauss	director	P O BOX 1734, ATLANTA GA 30301
Bradley E Lerman	director	MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Dominic J Caruso	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Webster Roy Dunbar	director	5757 N. GREEN BAY AVENUE, MILWAUKEE WI 53209
James H. Hinton	director	6555 NORTH STATE HWY. 161, IRVING TX 75039